Abstract Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the
human race, and prophylactic vaccination is the most potent approach to end this pandemic …

Respiratory syncytial virus (RSV) is responsible for a significant proportion of global
morbidity and mortality affecting young children and older adults. In the aftermath of formalin …

Human cytomegalovirus (HCMV) infection, the most common cause of congenital disease
globally, affecting an estimated 1 million newborns annually, can result in lifelong sequelae …

Over recent decades, therapeutic proteins have had widespread success in treating a
myriad of diseases. Glycosylation, a near universal feature of this class of drugs, is a critical …

Approved vaccines prevent 2 to 3 million deaths per year. There is a lack of equitable
access to vaccines in the low-and middle-income developing nations. Challenges in the life …

Vaccines have proven effective in the treatment and prevention of numerous diseases.
However, traditional attenuated and inactivated vaccines suffer from certain drawbacks such …

Intranasal vaccines are anticipated to be powerful tools for combating many infectious
diseases, including SARS-CoV-2, because they induce not only systemic immunity but also …

Introduction The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and …

Rabies is a disease of antiquity and has a history spanning millennia ever since the first
interactions between humans and dogs. The alarming fatalities caused by this disease have …

COVID-19 is still prevalent around the globe. Although some SARS-CoV-2 vaccines have
been distributed to the population, the shortcomings of vaccines and the continuous …